Development and Validation of the Prediction Model for Functional Mitral Regurgitation Regression in Heart Failure Patients Taking Guideline-directed Medical Therapy
Status: Unknown
Location: See location...
Intervention Type: Drug, Other
Study Type: Observational
SUMMARY
This observational study is to develop and validate the prediction model for functional mitral regurgitation regression in heart failure patients taking GDMT. The patients diagnosed ≥2+ functional mitral regurgitation by ultrasonic cardiogram are enrolled in this study and would be clinically followed by at least one year (clinical visit at 3 months, 6 months, and 12 months), and then by when the endpoints are reached.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age\>18 years old
• ≥2+ FMR
• Receiving GDMT
Locations
Other Locations
China
Sun-Yatsen Memorial Hospital
RECRUITING
Guangzhou
Contact Information
Primary
Maohuan Lin
Maohuan_Lin@163.com
+86 13580575861
Time Frame
Start Date: 2024-01-01
Completion Date: 2025-12-31
Participants
Target number of participants: 270
Treatments
Regression group
Regression group contains the patients whose FMR regresses after taking GDMT for at least 3 months.
No-reaction group
No-reaction group contains the patients whose FMR has no regression by every clinical visit.
Related Therapeutic Areas
Sponsors
Leads: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University